Latest Regulatory News

Page 564 of 628
Suncorp Group Limited has announced a cash return of capital of AUD 3.00 per share, backed by shareholder and regulatory approvals, with payments scheduled for early March 2025.
Claire Turing
Claire Turing
12 Feb 2025
Amotiv Limited has announced a fully franked interim dividend of AUD 0.185 per share for the half-year ending December 2024, signaling steady financial health and shareholder returns.
Victor Sage
Victor Sage
12 Feb 2025
Suncorp Group Limited has announced a combined ordinary and special dividend totaling AUD 0.63 per security, fully franked and backed by APRA approval for a capital reduction. The payment is scheduled for mid-March 2025.
Claire Turing
Claire Turing
12 Feb 2025
Genesis Energy and New Zealand’s top generators are exploring extending Huntly Power Station’s life to address supply risks highlighted by winter 2024’s energy crunch.
Maxwell Dee
Maxwell Dee
12 Feb 2025
The Commonwealth Bank of Australia has released its December 2024 Basel III Pillar 3 report, reaffirming strong capital adequacy and liquidity positions despite evolving regulatory frameworks.
Victor Sage
Victor Sage
12 Feb 2025
Commonwealth Bank of Australia reported a 2.3% increase in cash NPAT for the half year ended December 2024, underpinned by disciplined lending growth and robust capital management. The bank maintained its leadership in customer engagement and digital innovation while navigating ongoing economic uncertainties.
Victor Sage
Victor Sage
12 Feb 2025
SIV Capital Limited reported a sharp increase in losses for the half-year ending December 2024 and remains suspended from ASX trading due to operational concerns. The company is exploring acquisitions to leverage substantial tax losses and restore market confidence.
Claire Turing
Claire Turing
11 Feb 2025
BMG Resources has addressed ASX's query on recent share price and volume spikes, confirming no undisclosed information but highlighting imminent assay results from its Abercromby Gold Project.
Maxwell Dee
Maxwell Dee
11 Feb 2025
Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.
Ada Torres
Ada Torres
11 Feb 2025
Sarama Resources has completed the second tranche of its A$2 million equity placement, issuing options to institutional investors after shareholder approval. The funds are earmarked for advancing exploration and supporting working capital.
Maxwell Dee
Maxwell Dee
11 Feb 2025
Bryah Resources has successfully completed the first tranche of its capital raising, securing $370,542 to fund copper exploration and working capital. The company now looks ahead to shareholder approval for the next phase of its placement.
Maxwell Dee
Maxwell Dee
11 Feb 2025
The Takeovers Panel has declined to hear Global Lithium Resources’ review application concerning alleged undisclosed shareholder associations ahead of its upcoming AGM, citing procedural timing issues.
Maxwell Dee
Maxwell Dee
11 Feb 2025